Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in amyloidosis

A S Cohen1, L A Jones

  • 1Boston University School of Medicine, Massachusetts.

Current Opinion in Rheumatology
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Recent advances in amyloidosis research include new mouse models and a deeper understanding of protein mutations. Treatment strategies are evolving, with liver transplantation showing promise for familial amyloid polyneuropathy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Solar irradiance and ENSO affect food security in Lake Tanganyika, a major African inland fishery.

Science advances·2020
Same author

Corrigendum to 'Plasma concentrations of long chain N-3 fatty acids in early and mid-pregnancy and risk of early preterm birth'.

EBioMedicine·2020
Same author

Plasma Concentrations of Long Chain N-3 Fatty Acids in Early and Mid-Pregnancy and Risk of Early Preterm Birth.

EBioMedicine·2018
Same author

Oil extraction imperils Africa's Great Lakes.

Science (New York, N.Y.)·2016
Same author

Elevated fetal steroidogenic activity in autism.

Molecular psychiatry·2014
Same author

Paroxysmal hemicrania responding to topiramate.

BMJ case reports·2011
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Nephrology

Background:

  • Amyloidosis encompasses a group of diseases characterized by the deposition of misfolded proteins in various organs.
  • Understanding the genetic basis and protein polymorphism is crucial for diagnosing and treating amyloidosis.
  • Previous research has focused on amyloid beta protein, transthyretin, and prion protein.

Purpose of the Study:

  • To review major advances in the understanding and treatment of amyloidoses over the past year.
  • To highlight new findings in protein polymorphism, genetic mutations, and disease models.
  • To discuss the expanding spectrum of clinical manifestations and emerging therapeutic strategies.

Main Methods:

  • Review of recent scientific literature on amyloidosis.

Related Experiment Videos

  • Analysis of studies on serum amyloid A protein polymorphism.
  • Evaluation of new animal models for primary amyloidosis.
  • Examination of genetic mutations in transthyretin and gelsolin.
  • Assessment of clinical data on beta 2-microglobulin-associated amyloidosis.
  • Review of treatment strategies, including liver transplantation.

    • Main Results:

    • A better understanding of serum amyloid A protein polymorphism and a new mouse model for primary amyloidosis have emerged.
    • The spectrum of transthyretin mutations and their varied clinical manifestations continue to be elucidated.
    • Gelsolin amyloidosis has been identified beyond Finland, and beta 2-microglobulin-related hemodialysis amyloidosis presents with extensive osteoarticular lesions.
    • Research has heavily focused on amyloid beta protein, amyloid precursor protein in Alzheimer's disease, and prion protein in spongiform encephalopathies.
    • Widespread systemic involvement leads to diverse clinical presentations of amyloidosis.

    Conclusions:

    • Significant progress has been made in understanding the molecular basis and clinical spectrum of various amyloidoses.
    • Emerging treatment approaches, such as liver transplantation for familial amyloid polyneuropathy, offer new hope for patients.
    • Continued research into protein structure, genetic factors, and disease mechanisms is essential for developing effective therapies.